Bio Medica Laboratories IPO vs Natrinai Ventures IPO

Comparison between Bio Medica Laboratories IPO and Natrinai Ventures IPO.

IPO Details

Bio Medica Laboratories IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Natrinai Ventures IPO is a SME Bookbuilding proposed to list at BSE SME.

Issue Size and Price

The total issue size of Bio Medica Laboratories IPO is up to ₹49.80 Cr whereas the issue size of the Natrinai Ventures IPO is up to ₹0.00 Cr. The final issue price of Bio Medica Laboratories IPO is ₹139.00 per share and of Natrinai Ventures IPO is .

 Bio Medica Laboratories IPONatrinai Ventures IPO
Face Value₹10 per share₹10 per share
Issue Price (Lower)₹132.00 per share
Issue Price (Upper)₹139.00 per share
Issue Price (Final)₹139.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size1000 shares
Fresh Issue Size32,06,000 shares41,40,000 shares
Fresh Issue Size (Amount)up to ₹44.56 Crup to ₹0.00 Cr
OFS Issue Size3,77,000 shares2,20,200 shares
OFS Issue Size (Amount)up to ₹5.24 Crup to ₹0.00 Cr
Issue Size Total35,83,000 shares43,60,200 shares
Issue Size Total (Amount)up to ₹49.80 Crup to ₹0.00 Cr

IPO Timetable

Bio Medica Laboratories IPO opens on May 21, 2026, while Natrinai Ventures IPO opens on . The closing date of Bio Medica Laboratories IPO and Natrinai Ventures IPO is May 25, 2026, and , respectively.

Financials & KPIs

Bio Medica Laboratories IPO P/E ratio is 13.03, as compared to Natrinai Ventures IPO P/E ratio of .

 Bio Medica Laboratories IPONatrinai Ventures IPO
Financials

Company Financials (Restated)

Period Ended30 Nov 202531 Mar 202531 Mar 202431 Mar 2023
Assets65.1739.1219.5317.57
Total Income28.6338.3315.3416.25
Profit After Tax8.669.792.500.33
EBITDA13.4515.215.631.70
NET Worth17.1214.734.942.44
Reserves and Surplus7.945.554.842.34
Total Borrowing38.1715.0110.499.61
Amount in ₹ Crore

Company Financials (Restated Standalone)

Period Ended31 Mar 202531 Mar 202431 Mar 2023
Assets69.8372.4821.43
Total Income157.98111.5064.79
Profit After Tax15.556.201.42
EBITDA21.898.312.02
NET Worth24.689.132.17
Reserves and Surplus12.988.681.83
Total Borrowing13.299.402.74
Amount in ₹ Crore
Promoter Shareholding (Pre-Issue)96.8499.98
Promoter Shareholding (Post-Issue)
P/E Ratio13.03
Market Cap₹174.79 Cr.
ROE99.5992.02
ROCE48.2081.05
Debt/Equity1.020.54
EPS₹10.67
RoNW99.5963.02

Shares Offered

In the Bio Medica Laboratories IPO Retail Individual Investors (RII) are offered 17,92,000 shares while in Natrinai Ventures IPO retail investors are offered 17,92,000 shares. Qualified Institutional Buyers (QIB) are offered 36,000 shares in Bio Medica Laboratories IPO and 0 shares in Natrinai Ventures IPO.

 Bio Medica Laboratories IPONatrinai Ventures IPO
Anchor Investor Reservation0 shares0 shares
Market Maker Reservation1,89,000 shares0 shares
QIB36,000 shares0 shares
NII17,55,000 shares0 shares
RII17,92,000 shares0 shares
Employee0 shares0 shares
Others
Total35,83,000 shares0 shares

Bids Received (Subscription)

Bio Medica Laboratories IPO subscribed 2.26x in total, whereas Natrinai Ventures IPO subscribed .

Compare with others

Compare:

Bio Medica Laboratories IPO Vs Natrinai Ventures IPO